Total Payments
$487,246
2024 Payments
$29,214
Companies
16
Transactions
424
Medicare Patients
427
Medicare Billing
$105,132
Payment Breakdown by Category
Other$323,617 (66.4%)
Consulting$83,040 (17.0%)
Travel$72,381 (14.9%)
Food & Beverage$8,209 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $321,727 | 83 | 66.0% |
| Consulting Fee | $83,040 | 25 | 17.0% |
| Travel and Lodging | $72,381 | 184 | 14.9% |
| Food and Beverage | $8,209 | 131 | 1.7% |
| Honoraria | $1,890 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TAIHO ONCOLOGY, INC. | $149,895 | 146 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $132,409 | 87 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $75,734 | 54 | $0 (2024) |
| Genentech USA, Inc. | $47,694 | 50 | $0 (2019) |
| Seagen Inc. | $22,516 | 19 | $0 (2023) |
| Daiichi Sankyo Inc. | $14,313 | 7 | $0 (2021) |
| ARRAY BIOPHARMA INC | $13,431 | 11 | $0 (2023) |
| Exelixis Inc. | $10,727 | 23 | $0 (2022) |
| PFIZER INC. | $10,283 | 12 | $0 (2023) |
| Amgen Inc. | $3,245 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,214 | 19 | E.R. Squibb & Sons, L.L.C. ($19,671) |
| 2023 | $152,611 | 98 | AstraZeneca Pharmaceuticals LP ($105,795) |
| 2022 | $81,051 | 80 | E.R. Squibb & Sons, L.L.C. ($26,495) |
| 2021 | $31,183 | 19 | Daiichi Sankyo Inc. ($14,313) |
| 2020 | $7,630 | 4 | ARRAY BIOPHARMA INC ($3,780) |
| 2019 | $72,923 | 96 | Taiho Oncology, Inc. ($67,579) |
| 2018 | $56,052 | 53 | Taiho Oncology, Inc. ($42,742) |
| 2017 | $56,583 | 55 | Genentech USA, Inc. ($36,146) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $8,200.00 | General |
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $537.04 | General |
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $95.78 | General |
| Category: Oncology | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $409.51 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $170.00 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $56.67 | General |
| 07/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $13,800.00 | General |
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $34.29 | General |
| Category: Oncology | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $28.75 | General |
| Category: Oncology | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $25.55 | General |
| Category: Oncology | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Oncology | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $205.17 | General |
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $1,122.49 | General |
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $1,122.49 | General |
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $510.70 | General |
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $199.60 | General |
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $199.60 | General |
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $73.97 | General |
| 12/21/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,176.00 | General |
| Category: Oncology | ||||||
| 12/21/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $32.75 | General |
| Category: Oncology | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $814.48 | General |
| Category: Oncology | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: Oncology | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $115.31 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 93 | 248 | $38,778 | $25,818 |
| 2022 | 3 | 82 | 213 | $35,934 | $22,621 |
| 2021 | 3 | 109 | 356 | $55,984 | $39,400 |
| 2020 | 7 | 143 | 303 | $31,930 | $17,293 |
Total Patients
427
Total Services
1,120
Medicare Billing
$105,132
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 53 | 205 | $31,337 | $21,269 | 67.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $5,275 | $3,521 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 17 | $2,166 | $1,029 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 46 | 173 | $29,375 | $18,397 | 62.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 24 | 24 | $4,791 | $3,217 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 16 | $1,768 | $1,006 | 56.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 58 | 290 | $45,692 | $32,479 | 71.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 29 | 29 | $6,560 | $4,169 | 63.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 37 | $3,732 | $2,753 | 73.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 37 | 149 | $12,832 | $8,992 | 70.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 22 | 39 | $5,019 | $2,945 | 58.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $2,539 | $1,687 | 66.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 18 | 18 | $3,039 | $1,665 | 54.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 32 | $2,041 | $1,213 | 59.4% |
| 99422 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes | Facility | 2020 | 16 | 24 | $3,576 | $503.46 | 14.1% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Facility | 2020 | 15 | 28 | $2,884 | $288.05 | 10.0% |
About Dr. Mohamed Salem, MD
Dr. Mohamed Salem, MD is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497882369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Salem, MD has received a total of $487,246 in payments from pharmaceutical and medical device companies, with $29,214 received in 2024. These payments were reported across 424 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($321,727).
As a Medicare-enrolled provider, Salem has provided services to 427 Medicare beneficiaries, totaling 1,120 services with total Medicare billing of $105,132. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Charlotte, NC
- Active Since 02/27/2007
- Last Updated 07/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497882369
Products in Payments
- Lonsurf (Drug) $138,684
- IMFINZI (Biological) $121,516
- OPDIVO (Biological) $48,269
- Avastin (Biological) $47,694
- BRAFTOVI (Drug) $23,341
- TUKYSA (Drug) $22,516
- Enhertu (Drug) $14,313
- LONSURF (Drug) $11,211
- Cabometyx (Drug) $9,077
- LUMAKRAS (Drug) $3,245
- CABOMETYX (Drug) $1,650
- MEKTOVI (Drug) $102.95
- TAGRISSO (Drug) $95.16
- FOUNDATIONACT (Device) $30.15
- SCS IPGs (Device) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601